Joe is the CEO of Retro Biosciences, which uses high-throughput, high-dimensional approaches to develop therapies for diseases driven by the biology of aging. Joe has had an academic background at Harvard, MIT, and Caltech, over 100 patents and applications. He founded two prior companies and spent several years as a part-time partner at Y Combinator. He continues to invest in and advise numerous biotechs.